VPC-13566 structure
|
Common Name | VPC-13566 | ||
|---|---|---|---|---|
| CAS Number | 218464-59-6 | Molecular Weight | 258.32 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H14N2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VPC-13566VPC-13566 is an advanced BF3-specific small molecule that was previously reported to effectively inhibit AR transcriptional activity and to displace the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines, including an enzalutamide-resistant cell line, and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice. |
| Name | VPC-13566 |
|---|
| Description | VPC-13566 is an advanced BF3-specific small molecule that was previously reported to effectively inhibit AR transcriptional activity and to displace the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines, including an enzalutamide-resistant cell line, and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice. |
|---|
| Molecular Formula | C18H14N2 |
|---|---|
| Molecular Weight | 258.32 |
| InChIKey | FPKBNOVQNMJTEJ-UHFFFAOYSA-N |
| SMILES | Cc1cccc2c(-c3ccc4ccccc4n3)c[nH]c12 |